SPHK2 and central nervous system cancer: While both SPHK1 and SPHK2 participate in the phosphorylation of sphingosine, the expression of SPHK1 is elevated in IDHwt glioma patients and is highly correlated with a worse prognosis compared to SPHK2 [39].